ELITEK: payments to doctors
Payments that named ELITEK as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.7M
- Providers
- 5,493
- Transactions
- 16,337
- Average per transaction
- $107
The per-transaction average — $107 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,493 providers the average total is $318, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi | $1,631,244 | 93.3% |
| Sanofi-aventis U.S. LLC | $70,295 | 4.0% |
| Bioverativ Therapeutics Inc. | $47,377 | 2.7% |